Vous avez cherché: tumorrespons (Danois - Anglais)

tid til tumorrespons (måneder)
time to tumour response (months)

tumorrespons blev evalueret hver 4. uge.
assessment of tumour response was conducted every 4 weeks.

bedste tumorrespons (investigators gennemgang)
best tumour response (investigator assessment)

seneste tumorrespons bedømt af investigator.
estimates were calculated by hazard ratios 2) last tumour response as assessed by the investigator.

det primære endpoint var bedste tumorrespons.
the primary endpoint was best tumour response.

2) seneste tumorrespons bedømt af investigator.
2) last tumour response as assessed by the investigator.

bedste tumorrespons i undersøgelse stib2222 (gist)
best tumour response in trial stib2222 (gist)

objektivt tumorrespons / varighed af respons/progression
objective tumour responses / duration of response / progression

tabel 6 bedste tumorrespons i undersøgelse stib2222 (gist)
table 6 best tumour response in trial stib2222 (gist)

i dette studie blev antitumoraktivitet målt som bedste samlede tumorrespons.
in this study, antitumor activity was measured by best overall tumour response.

10 patienter opnåede en tumorrespons på grund af den anden behandling.
ten patients achieved a tumour response due to re-treatment.

estimater beregnet ved hazard ratio 2) seneste tumorrespons bedømt af investigator.
0.0003 0.0005 0.9449na na naestimates were calculated by hazard ratios 2) last tumour response as assessed by the investigator.

tumorrespons øges hos patienter med fuldt belyste læsioner med en dybde på 10mm eller mindre.
tumour responses are enhanced in patients with fully illuminated lesions of 10mm or less in depth.

i adskillige undersøgelser mangler imidlertid de objektive kriterier for evaluering af tumorrespons eller er ikke rapporteret.
however, in several studies, the objective criteria for evaluating tumour response are missing or not reported.

tumorrespons var uafhængigt af odomzo-dosis eller -plasmakoncentrationer i dosisområdet 200 mg til 800 mg.
tumour response was independent of odomzo dose or plasma concentration in the dose range of 200 mg to 800 mg.

den mediane observerede varighed af tumorrespons for samtlige patienter var 57 dage for respons generelt og 84 dage for komplet respons.
the median observed duration of tumour response for all patients was 57 days for overall response and 84 days for complete response.

blandt forsøgspersoner med registrerbar bløddelssygdom blev der set signifikant flere tilfælde af fuldstændigt eller delvist tumorrespons med zytiga-behandling.
in subjects with measurable soft tissue disease, significantly increased numbers of complete and partial tumor responses were seen with zytiga treatment.

tillæg af avastin til ifn alfa- 2a forøgede den progressionsfri overlevelse og den objektive tumorrespons signifikant (tabel 11).
the addition of avastin to ifn alfa-2a significantly increased pfs and objective tumour response rate (table 11).

behandlingen skal opretholdes i tilfælde af stabil sygdom, dvs. statisk, delvis eller komplet tumorrespons, forudsat at midlet tåles tilstrækkelig godt.
treatment should be maintained in the case of stable disease, i.e. static, partial or complete tumour response, provided that the product is sufficiently well tolerated.

behandlingen skal fortsætte, hvis sygdommen er stabil, dvs. ved statisk, delvis eller komplet tumorrespons, forudsat at hunden tåler behandlingen tilstrækkelig godt.
treatment should be maintained in the case of stable disease, i.e. static, partial or complete tumour response, provided that the product is sufficiently well tolerated.